Guidelines for treatment of renal injury during cancer chemotherapy 2016

Shigeo Horie; Mototsugu Oya; Masaomi Nangaku; Yoshinari Yasuda; Yasuhiro Komatsu; Motoko Yanagita; Yuko Kitagawa; Hiroyuki Kuwano; Hiroyuki Nishiyama; Chikashi Ishioka; Hiromasa Takaishi; Hideki Shimodaira; Akira Mogi; Yuichi Ando; Koji Matsumoto; Daisuke Kadowaki; Satoru Muto

doi:10.1007/s10157-017-1448-z

Guidelines for treatment of renal injury during cancer chemotherapy 2016

Clin Exp Nephrol. 2018 Feb;22(1):210-244. doi: 10.1007/s10157-017-1448-z.

Authors

Shigeo Horie^{1

2}, Mototsugu Oya³, Masaomi Nangaku⁴, Yoshinari Yasuda⁵, Yasuhiro Komatsu⁶, Motoko Yanagita⁷, Yuko Kitagawa⁸, Hiroyuki Kuwano⁹, Hiroyuki Nishiyama¹⁰, Chikashi Ishioka¹¹, Hiromasa Takaishi¹², Hideki Shimodaira¹¹, Akira Mogi⁹, Yuichi Ando¹³, Koji Matsumoto¹⁴, Daisuke Kadowaki¹⁵, Satoru Muto^{16

17}

Affiliations

¹ Department of Urology, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. [email protected].
² Department of Advanced Informatics for Genetic Disease, Juntendo University Graduate School of Medicine, Tokyo, Japan. [email protected].
³ Department of Urology, Keio University School of Medicine, Tokyo, Japan.
⁴ Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
⁵ Department of CKD Initiatives/Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
⁶ Division of Nephrology, Department of Medicine, St. Luke's International Hospital, Tokyo, Japan.
⁷ Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
⁸ Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
⁹ Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
¹⁰ Department of Urology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
¹¹ Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Miyagi, Japan.
¹² Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
¹³ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Aichi, Japan.
¹⁴ Division of Medical Oncology, Hyogo Cancer Center, Hyogo, Japan.
¹⁵ Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
¹⁶ Department of Urology, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
¹⁷ Department of Advanced Informatics for Genetic Disease, Juntendo University Graduate School of Medicine, Tokyo, Japan.

No abstract available

Publication types

Practice Guideline
Review

MeSH terms

Acute Kidney Injury / chemically induced*
Acute Kidney Injury / diagnosis
Acute Kidney Injury / physiopathology
Acute Kidney Injury / therapy*
Antineoplastic Agents / adverse effects*
Consensus
Evidence-Based Medicine / standards
Glomerular Filtration Rate / drug effects*
Humans
Kidney / drug effects*
Kidney / physiopathology
Nephrology / standards*
Predictive Value of Tests
Renal Insufficiency, Chronic / chemically induced*
Renal Insufficiency, Chronic / diagnosis
Renal Insufficiency, Chronic / physiopathology
Renal Insufficiency, Chronic / therapy*
Risk Factors
Treatment Outcome

Substances

Antineoplastic Agents